Live Breaking News & Updates on Mark Breidenbach

Stay updated with breaking news from Mark breidenbach. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BioLineRx Ltd. (NASDAQ:BLRX) Q1 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to the BioLineRx First Quarter 2023 Financial Results Conference Call. ....

Kevin Campbell , Phil Serlin , Eric Sapp , Mark Breidenbach , Genzyme Sanofi , Joe Pantginis , John Lacey , Ella Sorani , Tami Rachmilewitz , Philip Serlin , John Vandermosten , Corporate Communications Biolinerx , Washington University School Of Medicine , Columbia University , Market Development , Program Scientific Advisory Board , Biolinerx Ltd , Call Transcript May , Biolinerx First Quarter , Results Conference , Investor Relations , Corporate Communications , Chief Executive Officer , Mali Zeevi , Chief Financial Officer , Chief Development Officer ,

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q1 2023 Earnings Call Transcript

Operator: Good morning, and welcome to Syros Pharmaceuticals First Quarter 2023 Financial Results Conference Call. [Operator Instructions]. ....

United States , Nancy Simonian , Jason Butler , Jason Haas , Karen Hunady , Conley Chee , David Roth , Piper Sandler , Eric Olson , Christian Stevens , Mark Breidenbach , Ted Tenthoff , Phil Nadeau , Corporate Communications At Syros , Health Photo , Syros Pharmaceuticals Inc , Syros Pharmaceuticals , Call Transcript May , Syros Pharmaceutical First Quarter , Results Conference , Investor Relations , Corporate Communications , Chief Executive Officer , Chief Medical Officer , Chief Financial , Chief Development Officer ,

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q1 2023 Earnings Call Transcript

Operator: Good morning, and welcome to Agios First Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. There will be a question-and-answer session at the end. ....

United States , Brian Goff , Tsveta Milanova , Mark Breidenbach , Cecilia Jones , Sarah Gheuens , Gregory Renza , Tess Romero , Salveen Richter , Greg Harrison , Divya Rao , Goldman Sachs , Agios Pharmaceuticals Inc , Head Of Research , University Of Utrecht , Gulf Cooperation Council , Rare Disease Drug Development , Agios Pharmaceuticals , Call Transcript May , Agio First Quarter , Agio Chief Financial Officer , Chief Executive Officer , Chief Medical Officer , Chief Commercial , Rare Disease Drug , Chief Commercial Officer ,

US FDA approves Seres Therapeutics' pill for deadly C. difficile infections

US FDA approves Seres Therapeutics' pill for deadly C. difficile infections
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Raghav Mahobe , Shinjini Ganguli , Aditya Samal , Mark Breidenbach , Maju Samuel , Joseph Thome , Seres Therapeutics Inc , Switzerland Based Ferring Pharmaceutical ,

FDA Approves Treatment for Deadly C. Difficile Infections

The FDA on Wednesday approved Seres Therapeutics s pill for treating a type of bacterial infection, giving an easier and standardized option to patients who often have to rely on individual donors for fecal transplants. ....

United States , Joseph Thome , Raghav Mahobe , Shinjini Ganguli , Aditya Samal , Maju Samuel , Mark Breidenbach , Seres Therapeutics Inc , Switzerland Based Ferring Pharmaceutical , C Diff Infection , Clostridium Difficile Infection , Lostridium Difficile Associated Disease , C Diff Associated Disease , Fecal Transplantation , Stool Transplant , Ecal Bacteriotherapy , Fecal Microbiota Transplantation , Mt Faecal Transplant Transplantation Bacteriotherapy Microbiota , Acterial Infection ,